An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome

被引:133
作者
Glintborg, Dorte [1 ]
Andersen, Marianne [1 ]
机构
[1] Odense Univ Hosp, Dept Endocrinol, DK-5000 Odense, Denmark
关键词
Polycystic ovary syndrome; hirsutism; androgens; insulin resistance; pituitary gland; BONE-MINERAL DENSITY; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; PIOGLITAZONE TREATMENT; ANDROGEN EXCESS; WEIGHT-LOSS; DEHYDROEPIANDROSTERONE-SULFATE; SERINE PHOSPHORYLATION; LUTEINIZING-HORMONE; CORTISOL METABOLISM;
D O I
10.3109/09513590903247873
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hirsutism is a common endocrine disorder, defined as increased growth of terminal hairs in a male pattern. Hirsutism is most often caused by polycystic ovary syndrome (PCOS), whereas only 5% patients are diagnosed with rare endocrine diseases. PCOS may be considered a multiorgan disease causing not only increased adrenal and ovarian sex hormone secretion but also changed secretion of gonadotrophins, growth hormone, and adrenocorticotrophic hormone (ACTH) from the pituitary. The majority of patients with PCOS are insulin resistant and PCOS is characterized by an increased inflammatory state with abdominal obesity and increased secretion of interleukins, chemokines, and adipokines. PCOS is therefore associated with an increased risk of the metabolic syndrome and type 2 diabetes (T2D). Patients with hirsutism present with increased bone mineral density despite decreased D-vitamin levels. The etiology to hirsutism and PCOS is most likely multifactorial including both genetic and environmental factors such as increased fetal stress and intrauterine growth retardation. In the present review, we give a comprehensive overview of the pathophysiology and multiple endocrine disturbances of hirsutism and PCOS.</.
引用
收藏
页码:281 / 296
页数:16
相关论文
共 78 条
[1]  
[Anonymous], 2003, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD003053
[2]   Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome [J].
Ardawi, MSM ;
Rouzi, AA .
FERTILITY AND STERILITY, 2005, 83 (06) :1708-1716
[3]   Idiopathic hirsutism [J].
Azziz, R ;
Carmina, E ;
Sawaya, ME .
ENDOCRINE REVIEWS, 2000, 21 (04) :347-362
[4]   Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level [J].
Azziz, R ;
Black, VY ;
Knochenhauer, ES ;
Hines, GA ;
Boots, LR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :946-950
[5]   The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report [J].
Azziz, Ricardo ;
Carmina, Enrico ;
Dewailly, Didier ;
Diamanti-Kandarakis, Evanthia ;
Escobar-Morreale, Hector F. ;
Futterweit, Walter ;
Janssen, Onno E. ;
Legro, Richard S. ;
Norman, Robert J. ;
Taylor, Ann E. ;
Witchel, Selina F. .
FERTILITY AND STERILITY, 2009, 91 (02) :456-488
[6]   HYPERSECRETION OF LUTEINIZING-HORMONE AND THE POLYCYSTIC-OVARY-SYNDROME [J].
BALEN, AH .
HUMAN REPRODUCTION, 1993, 8 :123-128
[7]   Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: Prospective, randomized, crossover trial [J].
Banaszewska, Beata ;
Pawelczyk, Leszek ;
Spaczynski, Robert Z. ;
Dziura, James ;
Duleba, Antoni J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) :456-461
[8]   Ghrelin levels are suppressed and show a blunted response to oral glucose in women with polycystic ovary syndrome [J].
Barber, Thomas M. ;
Casanueva, Felipe F. ;
Karpe, Fredrik ;
Lage, Mary ;
Franks, Stephen ;
McCarthy, Mark I. ;
Wass, John A. H. .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2008, 158 (04) :511-516
[9]   PITUITARY OVARIAN RESPONSES TO NAFARELIN TESTING IN THE POLYCYSTIC OVARY SYNDROME [J].
BARNES, RB ;
ROSENFIELD, RL ;
BURSTEIN, S ;
EHRMANN, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (09) :559-565
[10]   The android woman - A risky condition [J].
Bjorntorp, P .
JOURNAL OF INTERNAL MEDICINE, 1996, 239 (02) :105-110